​

Metagenomi (MGX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Metagenomi Revenue Highlights

Latest Revenue (Y)

$25.21M

Latest Revenue (Q)

$1.25M

Metagenomi Revenue by Period

Metagenomi Revenue by Year

DateRevenueChange
2025-12-31$25.21M-51.79%
2024-12-31$52.30M16.84%
2023-12-31$44.76M160.21%
2022-12-31$17.20M6978.19%
2021-12-31$243.00K-

Metagenomi generated $25.21M in revenue during NA 2025, up -51.79% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Metagenomi Revenue by Quarter

DateRevenueChange
2026-03-31$1.25M-68.09%
2025-12-31$3.91M-54.83%
2025-09-30$8.66M1.72%
2025-06-30$8.51M106.28%
2025-03-31$4.13M-57.07%
2024-12-31$9.61M-16.50%
2024-09-30$11.51M-42.45%
2024-06-30$20.01M79.30%
2024-03-31$11.16M-10.00%
2023-12-31$12.40M0.29%
2023-09-30$12.36M9.05%
2023-06-30$11.34M30.96%
2023-03-31$8.66M54.73%
2022-12-31$5.59M13.88%
2022-09-30$4.91M46.83%
2022-06-30$3.35M-
2022-03-31$3.35M-

Metagenomi generated $1.25M in revenue during Q1 2026, up -68.09% compared to the previous quarter, and up 12.98% compared to the same period a year ago.

Metagenomi Revenue Breakdown

Metagenomi Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 25Jun 25Mar 25
Operating Segments$8.66M$8.51M$4.13M

Metagenomi's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Operating Segments (100.00%).

Metagenomi Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
STROSutro Biopharma$102.48M$14.52M
DTILPrecision BioSciences$34.26M$10.84M
MGXMetagenomi$25.21M$1.25M
ATYRaTyr Pharma$190.00K-
IFRXInflaRx$61.80K$36.25K
ALXOALX Oncology--
CNTBConnect Biopharma--
ARTVArtiva Biotherapeutics--
QNCXQuince Therapeutics--
KLRSKalaris Therapeutics--

MGX Revenue FAQ

What is Metagenomi’s yearly revenue?

Metagenomi's yearly revenue for 2025 was $25.21M, representing a decrease of -51.79% compared to 2024. The company's yearly revenue for 2024 was $52.3M, representing an increase of 16.84% compared to 2023. MGX's yearly revenue for 2023 was $44.76M, representing an increase of 160.21% compared to 2022.

What is Metagenomi’s quarterly revenue?

Metagenomi's quarterly revenue for Q1 2026 was $1.25M, a -68.09% decrease from the previous quarter (Q4 2025), and a -69.76% decrease year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $3.91M, a -54.83% decrease from the previous quarter (Q3 2025), and a -59.32% decrease year-over-year (Q4 2024). MGX's quarterly revenue for Q3 2025 was $8.66M, a 1.72% increase from the previous quarter (Q2 2025), and a -24.80% decrease year-over-year (Q3 2024).

What is Metagenomi’s revenue growth rate?

Metagenomi's revenue growth rate for the last 3 years (2023-2025) was -43.67%, and for the last 5 years (2021-2025) was 10274.49%.